86-023-13048470428
Effective Reducing Pressure Prostamide Bimatoprost / Prostamide CAS 155206-00-1
Quick Details
English Name: Bimatoprost
Other Names : Prostamide
CAS Number 155206-00-1
Molecular Formula C25H37NO4
Molecular Weight 415.27
Appearance: crystalline solid
Grade:Pharma Grade
Related products
Manufacturer:CQSP
Application:
Chemical Properties Crystalline Solid
Shelf life:2 years
Purity:99%
Package:1kg/foil bag or as your inquiry
Usage Antiglaucoma. Synthetic prostamide; structurally related to prostaglandin F2a.
Usage Antiglaucoma. Synthetic prostamide; structurally related to prostaglandin F2α.
Usage Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. Usage Bimatoprost is an antiglaucoma agent. Bimatoprost is an synthetic prostamide; structurally related to prostaglandin F2α.
Standard:Enterprise Standard
Reference FOB Price:$1/g
MOQ:10g
Specification:ISO9001,USP,BP
Trade Mark:CQSP
Port:Shenzhen/Shanghai,China
Production Capacity:5000kg/month
Orign: China
Inspection: SGS, ISO9001
Package: Professional pretend packing
Shipping: DHL, EMS, FedEx, UPS
More details pls contact:Whatapp:86 13048470428
Skype/E-mail : summer at chembj.com
Description
Bimatoprost (marketed in the U.S., Canada and Europe by Allergan, under the trade name) is aprostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluidfrom the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.
Usage
Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
Packing foil bag or as required
COA
TEST SPECIFICATIONS RESULTS
Appearance White to yellow crystalline powder White crystalline powder
Identification A. Should meet the requirement Conforms
B. Should meet the requirement Conforms
Impurity A ≤0.5% N.D.
Impurity B ≤0.3% 0.075%
Loss on drying ≤0.5% 0.085%
Residue on Ignition ≤0.1% 0.045%
Residual solvent Ethanol≤0.5% 0.026%
Ethyl acetate≤0.5% N.D.
Tetrahydrofuran≤0.072% N.D.
Heavy Metal ≤20ppm Conforms
Assay 98.0%~102.0% (Calculated on the dried basis) 99.5%